Rule 4729:8-3-01 | Entities required to submit information.
The following entities are required to submit the specified dispensing, personal furnishing, or wholesale sale information in accordance with this chapter of the Administrative Code to the state board of pharmacy for the operation of the drug database:
(A) All pharmacies located within this state and licensed as a terminal distributor of dangerous drugs shall report all drugs listed in Chapter 4729:8-2 of the Administrative Code that are dispensed to outpatients.
(B) All pharmacies located outside this state and licensed as a terminal distributor of dangerous drugs shall report all drugs listed in Chapter 4729:8-2 of the Administrative Code that are dispensed to outpatients residing in this state.
(C) Except as provided in rule 4729:8-2-02 of the Administrative Code, all licensed drug distributors and terminal distributors of dangerous drugs located within this state that sell at wholesale drugs listed in Chapter 4729:8-2 of the Administrative Code to prescribers or terminal distributors of dangerous drugs shall report those drug transactions in accordance with the wholesale reporting requirements of this chapter.
(D) Except as provided in rule 4729:8-2-02 of the Administrative Code, all licensed drug distributors and terminal distributors of dangerous drugs located outside this state that sell at wholesale drugs listed in Chapter 4729:8-2 of the Administrative Code to prescribers or terminal distributors of dangerous drugs located within this state shall report those drug transactions in accordance with the wholesale reporting requirements of this chapter.
(E) Except as provided in rule 4729:8-2-02 of the Administrative Code, all prescribers, except veterinarians, located within this state shall report all drugs listed in Chapter 4729:8-2 of the Administrative Code that are personally furnished to patients.
(F) A retail dispensary licensed under Chapter 3796. of the Revised Code in accordance with section 4729.771 of the Revised Code.
(G) An opioid treatment program licensed as a terminal distributor of dangerous drugs is exempted from the reporting requirements of this division.
(1) An opioid treatment program shall report patient information via the central registry established in rule 5122-40-08 of the Administrative Code.
(2) Reporting of patient information pursuant to paragraph (G)(1) of this rule shall be made in compliance with Title 42 CFR Part 2 (4/1/2025).
Last updated August 4, 2025 at 7:46 AM
Supplemental Information